文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,358+ SCI 论文 与阿拉丁产品引用相关
2,303,472.95 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

5 项

设置提升方向
5-甲基胞嘧啶
MICROCHEMICAL JOURNAL · 2026 · IF 5.2

A molecularly imprinted electrochemical sensor based on a novel AuNPs/MQDs/NGR ternary composite for sensitive and selective adenine determination

Tao Liu,Dan Li,Wenying Hu,Amirah F. Kamaruddin,Zhisong Lu,Wei Sun

Reliable electrochemical determination of adenine (Ade) in biological samples remains challenging due to interference from structurally similar nucleobases, nonspecific adsorption, and instability of conventional sensing interfaces, which compromise selectivity and signal reproducibility. Here, we report an interface engineered electrochemical molecularly imprinted sensor based on disposable screen-printed electrodes (SPEs). The sensing platform integrates a poly( o -phenylenediamine) molecularly imprinted recognition layer with Au nanoparticles/MXene quantum dots/nitrogen-doped graphene (AuNPs/MQDs/NGR) nanocomposite transduction interface. MXene quantum dots (MQDs) provide abundant edge and terminal sites that promote uniform AuNPs nucleation and anchoring on NGR, forming a conductive and structurally stable sensing layer with reduced charge-transfer resistance. This engineered interface enables stable electropolymerization of the imprinted film and improves signal stability and electrode-to-electrode reproducibility. The sensor exhibited a linear response for Ade from 0.25 to 80.0 μM (R 2  = 0.992) with a detection limit of 0.094 μM and recoveries of 96.40–103.84% in human serum sample. This strategy provides a reproducible and selective electrochemical platform that addresses key limitations of current adenine sensors for analysis in complex biological matrices.

✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
BIOSENSORS & BIOELECTRONICS · 2023 · IF 12.6

Machine learning-assisted global DNA methylation fingerprint analysis for differentiating early-stage lung cancer from benign lung diseases

Dechan Lu,Yanping Chen,Longfeng Ke,Weilin Wu,Liwen Yuan,Shangyuan Feng,Zufang Huang,Yudong Lu,Jing Wang

DNA methylation plays a critical role in the development of human tumors. However, routine characterization of DNA methylation can be time-consuming and labor-intensive. We herein describe a sensitive, simple surface-enhanced Raman spectroscopy (SERS) approach for identifying the DNA methylation pattern in early-stage lung cancer (LC) patients. By comparing SERS spectra of methylated DNA bases or sequences with their counterparts, we identified a reliable spectral marker of cytosine methylation. To move toward clinical applications, we applied our SERS strategy to detect the methylation patterns of genomic DNA (gDNA) extracted from cell line models as well as formalin-fixed paraffin-embedded tissues of early-stage LC and benign lung diseases (BLD) patients. In a clinical cohort of 106 individuals, our results showed distinct methylation patterns in gDNA between early-stage LC (n = 65) and BLD patients (n = 41), suggesting cancer-induced DNA methylation alterations. Combined with partial least square discriminant analysis, early-stage LC and BLD patients were differentiated with an area under the curve (AUC) value of 0.85. We believe that the SERS profiling of DNA methylation alterations, together with machine learning could potentially offer a promising new route toward the early detection of LC.

CAS / MDL: 71-30-7 554-01-8
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
TALANTA · 2023 · IF 6.1

High-throughput profiling of RNA modifications by ultra-performance liquid chromatography coupled to complementary mass spectrometry: Methods, quality control, and applications

Gefei Huang,Feng Zhang,Dongying Xie,Yiming Ma,Pengxi Wang,Guodong Cao,Leijian Chen,Siyi Lin,Zhongying Zhao,Zongwei Cai

Although next-generation sequencing technology has been used to delineate RNA modifications in recent years, the paucity of appropriate converting reactions or specific antibodies impedes the accurate characterization and quantification of numerous RNA modifications, especially when these modifications demonstrate wide variations across developmental stages and cell types. In this study, we developed a high-throughput analytical platform coupling ultra-performance liquid chromatograph (UPLC) with complementary mass spectrometry (MS) to identify and quantify RNA modifications in both synthetic and biological samples. Sixty-four types of RNA modifications, including positional isomers and hypermodified ribonucleosides , were successfully monitored within a 16-min single run of UPLC–MS. Two independent methods to cross-validate the purity of RNA extracted from Caenorhabditis elegans ( C. elegans ) were developed using the coexisting C. elegans and Escherichia coli ( E. coli ) as a surveillance system. To test the validity of the method, we investigated the RNA modification landscape of three model organisms, C. elegans , E. coli , and Arabidopsis thaliana ( A. thaliana ). Both the identity and molarity of modified ribonucleosides markedly varied among the species. Moreover, our platform is not only useful for exploring the dynamics of RNA modifications in response to environmental cues (e.g., cold shock) but can also help with the identification of RNA-modifying enzymes in genetic studies. Cumulatively, our method presents a novel platform for the comprehensive analysis of RNA modifications, which will be of benefit to both analytical chemists involved in biomarker discovery and biologists conducting functional studies of RNA modifications.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES · 2023 · IF 3

Exploring urinary modified nucleosides as biomarkers for diabetic retinopathy: Development and validation of a ultra performance liquid chromatography-tandem mass spectrometry method

Chen Yao,Daizhu Lv,Xueqing Zhou,Pengcheng Fu,Wen Sun,Jinlian Chen,Huan Lin

The dynamic modification of RNA plays a crucial role in biological regulation and is strongly linked to human disease development and progression. Notably, modified nucleosides in urine have shown promising potential as early diagnostic biomarkers for various conditions. In this study, we developed and validated a rapid, sensitive, and accurate UPLC-MS/MS method for quantifying eight types of modified nucleosides ( N 1 -methyladenosine (m 1 A), N 6 -methyladenosine (m 6 A), 5-methyluridine (m 5 U), 5-taurinomethyl-2-thiouridine (τm 5 s 2 U), 5-methylcytidine (m 5 C), 2'-O-methylcytidine (Cm), N 1 -methylguanosine (m 1 G), and N 7 -methylguanosine (m 7 G) in human urine. Using the method, we measured the urinary concentrations of m 1 A, m 6 A, m 5 U, τm 5 s 2 U, m 5 C, Cm, m 1 G, and m 7 G in a total of 21 control individuals and 23 patients diagnosed with diabetic retinopathy (DR). Cm levels showed promise as a diagnostic marker for diabetic retinopathy (DR), with a significant value (P < 0.01) and an AUC of 0.735. Other modified nucleosides also exhibited significant differences within specific subpopulations. As non-proliferative diabetic retinopathy (NPDR) signifies the latent early stage of diabetic retinopathy, we developed a multivariate linear model that integrates patients' sex, age, height, and urinary concentration of modified nucleosides which aims to predict and differentiate between healthy individuals, NPDR patients, and proliferative diabetic retinopathy (PDR) patients. Encouragingly, the model achieved satisfactory accuracy rates: healthy (81%), NPDR (75%), and PDR (80%). Our findings provide valuable insights into the development of an early, cost-effective, and noninvasive diagnostic approach for diabetic retinopathy.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
EMBO JOURNAL · 2024 · IF 9.4

The global phosphorylation landscape of mouse oocytes during meiotic maturation

SunHongzheng,HanLongsen,GuoYueshuai,AnHuiqing,WangBing,ZhangXiangzheng,LiJiashuo,JiangYingtong,WangYue,SunGuangyi,ZhuShuai,TangShoubin,GeJuan,ChenMinjian,GuoXuejiang,WangQiang

Phosphorylation is a key post-translational modification regulating protein function and biological outcomes. However, the phosphorylation dynamics orchestrating mammalian oocyte development remains poorly understood. In the present study, we apply high-resolution mass spectrometry-based phosphoproteomics to obtain the first global in vivo quantification of mouse oocyte phosphorylation. Of more than 8000 phosphosites, 75% significantly oscillate and 64% exhibit marked upregulation during meiotic maturation, indicative of the dominant regulatory role. Moreover, we identify numerous novel phosphosites on oocyte proteins and a few highly conserved phosphosites in oocytes from different species. Through functional perturbations, we demonstrate that phosphorylation status of specific sites participates in modulating critical events including metabolism, translation, and RNA processing during meiosis. Finally, we combine inhibitor screening and enzyme-substrate network prediction to discover previously unexplored kinases and phosphatases that are essential for oocyte maturation. In sum, our data define landscape of the oocyte phosphoproteome, enabling in-depth mechanistic insights into developmental control of germ cells.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。